Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers
David de Gonzalo‐Calvo(Instituto de Salud Carlos III), Rocío Toro(Università Campus Bio-Medico), Maribel Quezada-Feijoó(Hospital Central de la Cruz Roja San José y Santa Adela), Mónica Ramos(Hospital Central de la Cruz Roja San José y Santa Adela), Sara Blasco-Turrión(Hospital Universitario Puerto Real), Alipio Mangas(Universidad de Cádiz), Óscar Campuzano(Universitat de Girona), Jordi Broncano(Hospital San Juan de la Cruz), Vicenta Llorente‐Cortés(Consejo Superior de Investigaciones Científicas), Rosa Ayala(Hospital Universitario 12 De Octubre), Francisco Morales(Hospital Universitario Virgen del Rocío), Pablo González(Solidus Biosciences (United States)), Alexandra Pérez‐Serra(Universitat de Girona), Ramón Brugada(Institut d'Investigació Biomèdica de Girona)
Cited by 25
Related Papers
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
|Blood|2014|429
Gender Differences in Clinical Manifestations of Brugada Syndrome
|Journal of the American College of Cardiology|2008|280
Microbiota alterations in proline metabolism impact depression
|Cell Metabolism|2022|226